bromodeoxyuridine has been researched along with glucagon-like peptide 2 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, P; Ashley, SW; Edelman, ER; Jacobs, DO; Kormi, N; Seifert, P; Shen, R; Tavakkolizadeh, A; Whang, EE; Zinner, MJ | 1 |
| M'Rabet, L; van Beek, NM; van den Berg, JJ; van't Land, B | 1 |
| Demchyshyn, L; Hartmann, B; Holst, JJ; Martin, GR; Sigalet, DL; Toney, K; Wallace, LE | 1 |
| Fujii, N; Hagio, M; Hara, H; Ishizuka, S; Iwaya, H | 1 |
| Billeschou, A; Hunt, J; Kissow, H | 1 |
5 other study(ies) available for bromodeoxyuridine and glucagon-like peptide 2
| Article | Year |
|---|---|
Glucagon-like peptide 2: a new treatment for chemotherapy-induced enteritis.
Topics: Animals; Antimetabolites, Antineoplastic; Body Weight; Bromodeoxyuridine; Enteritis; Fluorouracil; Glucagon-Like Peptide 2; Glucagon-Like Peptides; Intestinal Mucosa; Jejunum; Male; Morbidity; Peptides; Rats; Rats, Sprague-Dawley | 2000 |
Lactoferrin reduces methotrexate-induced small intestinal damage, possibly through inhibition of GLP-2-mediated epithelial cell proliferation.
Topics: Animals; Antimetabolites, Antineoplastic; Bromodeoxyuridine; Caco-2 Cells; Cell Division; Cells, Cultured; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Epithelial Cells; Female; Glucagon-Like Peptide 2; Glucagon-Like Peptides; Humans; Intestinal Mucosa; Lactoferrin; Methotrexate; Peptides; Polymerase Chain Reaction; Rats; Rats, Inbred Strains | 2004 |
Nutrient-stimulated GLP-2 release and crypt cell proliferation in experimental short bowel syndrome.
Topics: Adaptation, Physiological; Animals; Antimetabolites; Body Weight; Bromodeoxyuridine; Cell Proliferation; Dietary Fats; Dietary Proteins; Enzyme-Linked Immunosorbent Assay; Food; Glucagon-Like Peptide 2; Glucagon-Like Peptides; Intestinal Absorption; Intestinal Mucosa; Intestines; Male; Peptides; Rats; Rats, Sprague-Dawley; Short Bowel Syndrome | 2005 |
Contribution of dipeptidyl peptidase IV to the severity of dextran sulfate sodium-induced colitis in the early phase.
Topics: Animals; Bile Acids and Salts; Bromodeoxyuridine; Cecum; Colitis; Dextran Sulfate; Dipeptidyl Peptidase 4; Glucagon-Like Peptide 2; Male; Rats; Time Factors | 2013 |
Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis.
Topics: Acute Disease; Adaptation, Physiological; Animals; Antineoplastic Agents; Biomarkers; Body Weight; Bromodeoxyuridine; Cell Proliferation; Disease Models, Animal; Endpoint Determination; Female; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Intestinal Mucosa; Intestine, Small; Mice, Inbred C57BL; Mucositis | 2019 |